Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Rui Tu
Breast cancer is a complex and heterogeneous disease characterized by the presence of breast cancer stem cells (BCSCs). These BCSCs exhibit unique properties, including self-renewal, tumorigenicity, and resistance to therapy, which contribute significantly to disease progression and treatment challenges. Understanding the mechanisms governing BCSC adaptability and heterogeneity is crucial for the development of more effective breast cancer treatments. Recent research has revealed novel molecular regulators that play pivotal roles in these aspects of BCSC behavior. This abstract explores the concept of BCSCs and their role in breast cancer, discusses the adaptability and heterogeneity of BCSCs, and highlights emerging molecular regulators that offer promising avenues for therapeutic intervention. Targeting these regulators represents a potential breakthrough in breast cancer treatment, offering hope for improved outcomes for patients with this devastating disease.